Effects of Photobiomodulation on Changes in Cognitive Function and rCBF in MCI

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 12, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

June 30, 2020

Conditions
Regional Cerebral Blood FlowMild Cognitive ImpairmentCognitive Function
Interventions
DEVICE

Photobiomodulation device

In this study, PBM was applied using a machine made to be attached to the subject in the form of a probe. In this clinical trial, a low-intensity irradiation device (Color-DNA-WSF U) from Color seven was used to deliver visible light (610nm± 10nm wavelength, 3.0mW/㎠±20%) irradiation. PBM was applied 5 times a week for 8 weeks, 30 minutes per session.

Trial Locations (1)

50610

Pusan national university Yangsan Hospital, Gyeongsang

All Listed Sponsors
lead

Pusan National University Yangsan Hospital

OTHER

NCT04721093 - Effects of Photobiomodulation on Changes in Cognitive Function and rCBF in MCI | Biotech Hunter | Biotech Hunter